Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

April 26, 2017cells disorders epstein-barr key killer lymphoproliferative natural treating

0

Posted

Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

1 Answer

0

Posted

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder. [J Clin Invest. 2001] GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.Baiocchi RA, Ward JS, Carrodeguas L, Eisenbeis CF, Peng R, Roychowdhury S, Vourganti S, Sekula T, O’Brien M, Moeschberger M, et al. J Clin Invest. 2001 Sep; 108(6):887-94. Review Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. [Crit Rev Oncol Hematol. 2002] Review Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Crit Rev Oncol Hematol. 2002 Dec; 44(3):251-7. Review Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. [Springer Semin Immunopathol. 1998] R